Abstract
Supplemental Figure S6. Treatment of PDAC KRAS G12D mutant cells with the M1C ADC inhibits clonogenic survival. A. AsPC-1 and PANC-1 cells were analyzed by flow cytometry with a control IgG and anti-M1C. The bar plot depicts mean fluorescence intensity (MFI)-fold change (anti-M1C/IgG). The results (mean±SD of three determinations) are expressed as relative levels compared to that obtained for PANC-1 cells (assigned a value of 1). B and C. AsPC-1 (B), PANC-1 (C) and cells left untreated or treated with 50 nM M1C ADC for 6 days were analyzed for colony formation. Shown are representative photomicrographs of stained colonies (left). The results (mean±SD of three determinations) are expressed as relative colony number compared to that for untreated cells (assigned a value of 1)(right). D. AsPC-1 cells treated with 50 nM MRTX1133 and 20 nM M1C ADC for 6 days were analyzed for colony formation. Shown are representative photomicrographs of stained colonies. E. PANC-1 cells treated with 1 μM MRTX1133 and 20 nM M1C ADC for 6 days were analyzed for colony formation. Shown are representative photomicrographs of stained colonies. F. AsPC-1/MR cells left untreated or treated with 50 nM M1C ADC for 6 days were analyzed for colony formation. Shown are representative photomicrographs of stained colonies (left). The results (mean±SD of three determinations) are expressed as relative colony number compared to that for untreated cells (assigned a value of 1)(right). G. Lysates from AsPC-1/MR cells treated with 1 μM MRTX1133 for 2 days were immunoblotted with antibodies against the indicated proteins. H. AsPC-1/MR cells treated with 1 μM MRTX1133 for 2 days were analyzed by flow cytometry with a control IgG and anti-M1C. Shown are histograms for M1C expression (left). The bar plot shows the MFI, presented as the mean ± SD of three independent determinations (right). I. PANC-1/MR cells left untreated or treated with 50 nM M1C ADC for 6 days were analyzed for colony formation. Shown are representative photomicrographs of stained colonies (left). The results (mean±SD of three determinations) are expressed as relative colony number compared to that for untreated cells (assigned a value of 1)(right). J. Lysates from PANC-1/MR cells treated with 1 μM MRTX1133 for 2 days were immunoblotted with antibodies against the indicated proteins. K. PANC-1/MR cells treated with 1 μM MRTX1133 for 2 days were analyzed by flow cytometry with a control IgG and anti-M1C. Shown are histograms for M1C expression (left). The bar plot shows the MFI, presented as the mean ± SD of three independent determinations (right). L. AsPC-1/MR and PANC-1/MR cells treated with the indicated concentrations of the unconjugated huMAb 3D1 antibody for 6 days were analyzed for cell viability by Alamar Blue staining. The results (mean±SD of three determinations) are expressed as relative cell number (% control) compared to that for untreated cells. M. AsPC-1/MR and PANC-1/MR were treated with the indicated concentrations of the unconjugated huMAb 3D1 antibody and MRTX1133 for 6 days. Cell viability was assessed using Alamar Blue staining (mean of three determinations). Indicated are the combination indices determined using Bliss scores.